XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2020   91,502,461      
Beginning balance at Dec. 31, 2020 $ 130,670 $ 915 $ 1,176,647 $ (1,046,889) $ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,099   1,099    
Exercise of stock options (in shares)   31,811      
Exercise of stock options 79 $ 1 78    
Unrealized gain (loss) on marketable securities (6)       (6)
Net loss (9,927)     (9,927)  
Ending balance (in shares) at Mar. 31, 2021   91,534,272      
Ending balance at Mar. 31, 2021 121,915 $ 916 1,177,824 (1,056,816) (9)
Beginning balance (in shares) at Dec. 31, 2020   91,502,461      
Beginning balance at Dec. 31, 2020 130,670 $ 915 1,176,647 (1,046,889) (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (20,765)        
Ending balance (in shares) at Jun. 30, 2021   91,596,369      
Ending balance at Jun. 30, 2021 112,474 $ 916 1,179,215 (1,067,654) (3)
Beginning balance (in shares) at Mar. 31, 2021   91,534,272      
Beginning balance at Mar. 31, 2021 121,915 $ 916 1,177,824 (1,056,816) (9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,275   1,275    
Issuance of stock under Employee Stock Purchase Plan (in shares)   20,791      
Issuance of stock under Employee Stock Purchase Plan 68   68    
Exercise of stock options (in shares)   41,306      
Exercise of stock options 48   48    
Unrealized gain (loss) on marketable securities 6       6
Net loss (10,838)     (10,838)  
Ending balance (in shares) at Jun. 30, 2021   91,596,369      
Ending balance at Jun. 30, 2021 $ 112,474 $ 916 1,179,215 (1,067,654) (3)
Beginning balance (in shares) at Dec. 31, 2021 91,645,369 91,645,369      
Beginning balance at Dec. 31, 2021 $ 90,707 $ 916 1,182,225 (1,092,325) (109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,718   1,718    
Unrealized gain (loss) on marketable securities (342)       (342)
Net loss (16,109)     (16,109)  
Ending balance (in shares) at Mar. 31, 2022   91,645,369      
Ending balance at Mar. 31, 2022 $ 75,974 $ 916 1,183,943 (1,108,434) (451)
Beginning balance (in shares) at Dec. 31, 2021 91,645,369 91,645,369      
Beginning balance at Dec. 31, 2021 $ 90,707 $ 916 1,182,225 (1,092,325) (109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 0        
Net loss $ (32,049)        
Ending balance (in shares) at Jun. 30, 2022 91,814,665 91,814,665      
Ending balance at Jun. 30, 2022 $ 62,045 $ 918 1,186,056 (1,124,374) (555)
Beginning balance (in shares) at Mar. 31, 2022   91,645,369      
Beginning balance at Mar. 31, 2022 75,974 $ 916 1,183,943 (1,108,434) (451)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,966   1,966    
Issuance of stock under Employee Stock Purchase Plan (in shares)   169,296      
Issuance of stock under Employee Stock Purchase Plan 149 $ 2 147    
Unrealized gain (loss) on marketable securities (104)       (104)
Net loss $ (15,940)     (15,940)  
Ending balance (in shares) at Jun. 30, 2022 91,814,665 91,814,665      
Ending balance at Jun. 30, 2022 $ 62,045 $ 918 $ 1,186,056 $ (1,124,374) $ (555)